Sign in

CIK 0001177648

  • Non-accelerated filer
  • Smaller reporting company

ENANTA PHARMACEUTICALS INC

Sign in to watch
Ticker
ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Entity type
Operating
EIN
043205099
Phone
+1 617-607-0800
Business address
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-08 Rottinghaus Scott T. Chief Medical Officer Shares withheld for taxes −1,467 $13.34 $20K 23,787
2026-02-12 Rottinghaus Scott T. Chief Medical Officer Grant or award +1,650 23,442
2026-02-12 Rottinghaus Scott T. Chief Medical Officer Grant or award +5,225 28,667
2026-02-12 Rottinghaus Scott T. Chief Medical Officer Shares withheld for taxes −3,413 $14.25 $49K 25,254
2025-12-05 Rottinghaus Scott T. Chief Medical Officer Sale −798 $14.23 $11K 21,792
2025-11-25 Rottinghaus Scott T. Chief Medical Officer Grant or award · Stock Option (right to buy) +110,000 110,000
2025-08-08 Rottinghaus Scott T. Chief Medical Officer Shares withheld for taxes −2,217 $6.99 $15K 22,590
2025-02-12 Rottinghaus Scott T. Chief Medical Officer Grant or award +9,750 27,668
2025-02-12 Rottinghaus Scott T. Chief Medical Officer Shares withheld for taxes −2,861 $5.59 $16K 24,807
2024-12-06 Rottinghaus Scott T. Chief Medical Officer Sale 10b5-1 −866 $8.06 $7K 17,918
2024-11-27 Rottinghaus Scott T. Chief Medical Officer Grant or award · Stock Option (right to buy) +87,000 87,000
2024-08-08 Rottinghaus Scott T. Chief Medical Officer Shares withheld for taxes −1,466 $12.73 $19K 18,784
2024-07-15 Rottinghaus Scott T. Chief Medical Officer Option exercise 10b5-1 +5,375 $8.99 $48K 27,092
2024-07-15 Rottinghaus Scott T. Chief Medical Officer Sale 10b5-1 −5,375 $17.08 $92K 21,717
2024-07-15 Rottinghaus Scott T. Chief Medical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −5,375 80,625
2024-07-12 Rottinghaus Scott T. Chief Medical Officer Sale 10b5-1 −2,271 $15.04 $34K 21,717
2024-07-11 Rottinghaus Scott T. Chief Medical Officer Sale 10b5-1 −4,299 $15.07 $65K 23,988
2024-02-12 Rottinghaus Scott T. Chief Medical Officer Grant or award +2,576 29,042
2024-02-12 Rottinghaus Scott T. Chief Medical Officer Shares withheld for taxes −755 $12.41 $9K 28,287
2023-12-05 Rottinghaus Scott T. Sr. VP & CMO Sale −534 $9.63 $5K 26,466

Page 1 of 2 · 26 trades